Engineered gut bacteria show promise against pancreatic cancer

Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to treat. One major reason is that pancreatic tumors often create a “cold” tumor microenvironment, where the tumor prevents immune cells from mounting a strong attack.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup